Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China
· Delayed Price · Currency is CNY 9.56
-0.27 (-2.75%)
Apr 29, 2026, 3:00 PM CST
SHA:600867 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 19,104 | 15,878 | 15,712 | 21,483 | 18,210 | 22,161 | Upgrade
|
| Market Cap Growth | 31.02% | 1.06% | -26.86% | 17.97% | -17.83% | -17.92% | Upgrade
|
| Enterprise Value | 18,138 | 15,011 | 15,837 | 20,921 | 16,966 | 21,321 | Upgrade
|
| Last Close Price | 9.83 | 8.17 | 7.80 | 10.22 | 8.47 | 9.54 | Upgrade
|
| PE Ratio | 15.85 | 13.03 | - | 18.40 | 11.51 | 16.94 | Upgrade
|
| Forward PE | 27.98 | 31.42 | 42.42 | 20.43 | 16.39 | 23.83 | Upgrade
|
| PS Ratio | 6.48 | 5.39 | 7.82 | 6.99 | 6.55 | 6.78 | Upgrade
|
| PB Ratio | 2.69 | 2.23 | 2.46 | 2.98 | 2.78 | 3.56 | Upgrade
|
| P/TBV Ratio | 2.91 | 2.42 | 2.73 | 3.28 | 3.01 | 3.80 | Upgrade
|
| P/FCF Ratio | 111.37 | 92.57 | - | 41.84 | 49.19 | 38.23 | Upgrade
|
| P/OCF Ratio | 27.72 | 23.04 | 34.17 | 24.94 | 21.10 | 18.77 | Upgrade
|
| PEG Ratio | - | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | Upgrade
|
| EV/Sales Ratio | 6.15 | 5.09 | 7.88 | 6.80 | 6.11 | 6.52 | Upgrade
|
| EV/EBITDA Ratio | 20.80 | 17.32 | 52.79 | 14.37 | 16.42 | 15.35 | Upgrade
|
| EV/EBIT Ratio | 30.09 | 24.90 | 140.12 | 16.47 | 19.23 | 17.12 | Upgrade
|
| EV/FCF Ratio | 105.74 | 87.51 | - | 40.75 | 45.83 | 36.78 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.07 | 0.11 | 0.02 | 0 | 0 | Upgrade
|
| Debt / EBITDA Ratio | 0.60 | 0.60 | 2.30 | 0.10 | 0.00 | 0.00 | Upgrade
|
| Debt / FCF Ratio | 3.07 | 3.07 | - | 0.29 | 0.01 | 0.01 | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | -0.14 | 0.01 | -0.14 | -0.13 | -0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.12 | -1.12 | 0.17 | -0.69 | -0.82 | -0.65 | Upgrade
|
| Net Debt / FCF Ratio | -5.66 | -5.66 | -0.48 | -1.97 | -2.28 | -1.55 | Upgrade
|
| Asset Turnover | 0.39 | 0.39 | 0.27 | 0.42 | 0.42 | 0.53 | Upgrade
|
| Inventory Turnover | 1.21 | 1.21 | 0.76 | 0.91 | 1.05 | 1.09 | Upgrade
|
| Quick Ratio | 3.65 | 3.65 | 1.80 | 3.92 | 8.16 | 5.81 | Upgrade
|
| Current Ratio | 5.04 | 5.04 | 3.02 | 5.41 | 12.69 | 8.05 | Upgrade
|
| Return on Equity (ROE) | 17.73% | 17.73% | -0.65% | 16.97% | 24.77% | 22.22% | Upgrade
|
| Return on Assets (ROA) | 4.93% | 4.93% | 0.93% | 10.94% | 8.31% | 12.63% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.88% | 7.76% | 1.79% | 18.24% | 13.84% | 20.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.20% | 8.20% | 1.70% | 17.50% | 13.40% | 19.90% | Upgrade
|
| Earnings Yield | 6.38% | 7.68% | -0.27% | 5.44% | 8.69% | 5.90% | Upgrade
|
| FCF Yield | 0.90% | 1.08% | -0.69% | 2.39% | 2.03% | 2.61% | Upgrade
|
| Dividend Yield | 3.05% | - | 3.20% | 2.45% | 5.91% | 3.14% | Upgrade
|
| Payout Ratio | 41.45% | 41.45% | - | 42.49% | 69.27% | 32.49% | Upgrade
|
| Buyback Yield / Dilution | 6.27% | 7.96% | -7.92% | 1.15% | 2.04% | -1.12% | Upgrade
|
| Total Shareholder Return | 9.28% | 7.96% | -4.72% | 3.60% | 7.95% | 2.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.